KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Elevance Health (ELV) Shares Outstanding (2016 - 2025)

Elevance Health (ELV) has disclosed Shares Outstanding for 17 consecutive years, with $220.7 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding fell 2.97% to $220.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $220.7 million through Dec 2025, down 2.97% year-over-year, with the annual reading at $220.7 million for FY2025, 2.97% down from the prior year.
  • Shares Outstanding for Q4 2025 was $220.7 million at Elevance Health, down from $222.0 million in the prior quarter.
  • The five-year high for Shares Outstanding was $244.9 million in Q1 2021, with the low at $220.7 million in Q4 2025.
  • Average Shares Outstanding over 5 years is $234.5 million, with a median of $235.4 million recorded in 2023.
  • The sharpest move saw Shares Outstanding dropped 1.28% in 2024, then decreased 4.25% in 2025.
  • Over 5 years, Shares Outstanding stood at $241.8 million in 2021, then dropped by 1.57% to $238.0 million in 2022, then dropped by 2.06% to $233.1 million in 2023, then dropped by 2.41% to $227.5 million in 2024, then fell by 2.97% to $220.7 million in 2025.
  • According to Business Quant data, Shares Outstanding over the past three periods came in at $220.7 million, $222.0 million, and $224.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.